HAG
HF Advisory Group’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.35M | Buy |
137,999
+28,131
| +26% | +$682K | 1.32% | 18 |
|
2025
Q1 | $2.78M | Buy |
109,868
+18,466
| +20% | +$468K | 1.22% | 21 |
|
2024
Q4 | $2.42M | Buy |
91,402
+2,916
| +3% | +$77.4K | 1.11% | 27 |
|
2024
Q3 | $2.56M | Sell |
88,486
-1,418
| -2% | -$41K | 1.19% | 20 |
|
2024
Q2 | $2.52M | Buy |
89,904
+7,429
| +9% | +$208K | 1.3% | 14 |
|
2024
Q1 | $2.29M | Buy |
82,475
+14,864
| +22% | +$412K | 1.28% | 19 |
|
2023
Q4 | $1.95M | Buy |
67,611
+11,479
| +20% | +$330K | 1.24% | 22 |
|
2023
Q3 | $1.86M | Buy |
56,132
+7,983
| +17% | +$265K | 1.38% | 15 |
|
2023
Q2 | $1.77M | Buy |
48,149
+6,363
| +15% | +$233K | 1.4% | 15 |
|
2023
Q1 | $1.7M | Buy |
41,786
+5,143
| +14% | +$210K | 1.51% | 14 |
|
2022
Q4 | $1.88M | Buy |
+36,643
| New | +$1.88M | 1.9% | 9 |
|